<!DOCTYPE html>
<html >

<head>

  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>MP</title>
  <meta name="description" content="MP">
  <meta name="generator" content="bookdown 0.7 and GitBook 2.6.7">

  <meta property="og:title" content="MP" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="MP" />
  
  
  

<meta name="author" content="pqi">



  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black">
  
  
<link rel="prev" href="electron.html">
<link rel="next" href="protection.html">
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










<link rel="stylesheet" href="style.css" type="text/css" />
<link rel="stylesheet" href="font-awesome.min.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">A Minimal Book Example</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Welcome</a></li>
<li class="chapter" data-level="1" data-path="introduction.html"><a href="introduction.html"><i class="fa fa-check"></i><b>1</b> Introduction</a><ul>
<li class="chapter" data-level="1.1" data-path="introduction.html"><a href="introduction.html#constant"><i class="fa fa-check"></i><b>1.1</b> Physics constants</a></li>
<li class="chapter" data-level="1.2" data-path="introduction.html"><a href="introduction.html#atomic-rep"><i class="fa fa-check"></i><b>1.2</b> Atomic Representation</a></li>
<li class="chapter" data-level="1.3" data-path="introduction.html"><a href="introduction.html#stability"><i class="fa fa-check"></i><b>1.3</b> Stability</a></li>
<li class="chapter" data-level="1.4" data-path="introduction.html"><a href="introduction.html#mass-defect"><i class="fa fa-check"></i><b>1.4</b> Mass Defect</a></li>
<li class="chapter" data-level="1.5" data-path="introduction.html"><a href="introduction.html#einstein"><i class="fa fa-check"></i><b>1.5</b> High energy charged particles</a></li>
<li class="chapter" data-level="1.6" data-path="introduction.html"><a href="introduction.html#high-energy-photons"><i class="fa fa-check"></i><b>1.6</b> High energy photons</a></li>
<li class="chapter" data-level="1.7" data-path="introduction.html"><a href="introduction.html#electron-shell"><i class="fa fa-check"></i><b>1.7</b> Electron Shell</a></li>
<li class="chapter" data-level="1.8" data-path="introduction.html"><a href="introduction.html#solutions"><i class="fa fa-check"></i><b>1.8</b> Solutions</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="nut.html"><a href="nut.html"><i class="fa fa-check"></i><b>2</b> Nuclear Transformation</a><ul>
<li class="chapter" data-level="2.1" data-path="nut.html"><a href="nut.html#decays"><i class="fa fa-check"></i><b>2.1</b> Nuclear Decay (disintegration)</a><ul>
<li class="chapter" data-level="2.1.1" data-path="nut.html"><a href="nut.html#alpha"><i class="fa fa-check"></i><b>2.1.1</b> Alpha-decay</a></li>
<li class="chapter" data-level="2.1.2" data-path="nut.html"><a href="nut.html#beta"><i class="fa fa-check"></i><b>2.1.2</b> Beta-decay</a></li>
<li class="chapter" data-level="2.1.3" data-path="nut.html"><a href="nut.html#ec"><i class="fa fa-check"></i><b>2.1.3</b> Electron capture</a></li>
<li class="chapter" data-level="2.1.4" data-path="nut.html"><a href="nut.html#gamma"><i class="fa fa-check"></i><b>2.1.4</b> Gamma decay</a></li>
</ul></li>
<li class="chapter" data-level="2.2" data-path="nut.html"><a href="nut.html#activity"><i class="fa fa-check"></i><b>2.2</b> Activity</a></li>
<li class="chapter" data-level="2.3" data-path="nut.html"><a href="nut.html#solutions-1"><i class="fa fa-check"></i><b>2.3</b> Solutions</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="prox.html"><a href="prox.html"><i class="fa fa-check"></i><b>3</b> Production of X-rays</a><ul>
<li class="chapter" data-level="3.1" data-path="prox.html"><a href="prox.html#history"><i class="fa fa-check"></i><b>3.1</b> History</a></li>
<li class="chapter" data-level="3.2" data-path="prox.html"><a href="prox.html#conventional-x-ray-tubes"><i class="fa fa-check"></i><b>3.2</b> Conventional x-ray tubes</a><ul>
<li class="chapter" data-level="3.2.1" data-path="prox.html"><a href="prox.html#electron-source-cathode"><i class="fa fa-check"></i><b>3.2.1</b> Electron Source (Cathode)</a></li>
<li class="chapter" data-level="3.2.2" data-path="prox.html"><a href="prox.html#high-voltage"><i class="fa fa-check"></i><b>3.2.2</b> High voltage</a></li>
<li class="chapter" data-level="3.2.3" data-path="prox.html"><a href="prox.html#target-for-x-ray-production"><i class="fa fa-check"></i><b>3.2.3</b> Target for x-ray production</a></li>
<li class="chapter" data-level="3.2.4" data-path="prox.html"><a href="prox.html#target-x-ray-spectra"><i class="fa fa-check"></i><b>3.2.4</b> Target X-ray spectra</a></li>
</ul></li>
<li class="chapter" data-level="3.3" data-path="prox.html"><a href="prox.html#solutions-2"><i class="fa fa-check"></i><b>3.3</b> Solutions</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="gene.html"><a href="gene.html"><i class="fa fa-check"></i><b>4</b> Clinical Treatment Generators</a><ul>
<li class="chapter" data-level="4.1" data-path="gene.html"><a href="gene.html#history-1"><i class="fa fa-check"></i><b>4.1</b> History</a></li>
<li class="chapter" data-level="4.2" data-path="gene.html"><a href="gene.html#waveguide"><i class="fa fa-check"></i><b>4.2</b> Waveguide</a></li>
<li class="chapter" data-level="4.3" data-path="gene.html"><a href="gene.html#microwave-amplifier"><i class="fa fa-check"></i><b>4.3</b> Microwave amplifier</a></li>
<li class="chapter" data-level="4.4" data-path="gene.html"><a href="gene.html#microwave-frequency"><i class="fa fa-check"></i><b>4.4</b> Microwave frequency</a></li>
<li class="chapter" data-level="4.5" data-path="gene.html"><a href="gene.html#penumbra"><i class="fa fa-check"></i><b>4.5</b> Penumbra</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="inter.html"><a href="inter.html"><i class="fa fa-check"></i><b>5</b> Interaction</a><ul>
<li class="chapter" data-level="5.1" data-path="inter.html"><a href="inter.html#photo-el"><i class="fa fa-check"></i><b>5.1</b> Photoelectric interactions</a></li>
<li class="chapter" data-level="5.2" data-path="inter.html"><a href="inter.html#compton"><i class="fa fa-check"></i><b>5.2</b> Compton interactions</a></li>
<li class="chapter" data-level="5.3" data-path="inter.html"><a href="inter.html#pair"><i class="fa fa-check"></i><b>5.3</b> Pair production</a></li>
<li class="chapter" data-level="5.4" data-path="inter.html"><a href="inter.html#compton-interactions"><i class="fa fa-check"></i><b>5.4</b> Compton interactions</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="measurement.html"><a href="measurement.html"><i class="fa fa-check"></i><b>6</b> Measurement of Ionizing Radiation</a><ul>
<li class="chapter" data-level="6.1" data-path="measurement.html"><a href="measurement.html#collection-volume"><i class="fa fa-check"></i><b>6.1</b> Collection volume</a></li>
<li class="chapter" data-level="6.2" data-path="measurement.html"><a href="measurement.html#signal-of-an-ion-chamber"><i class="fa fa-check"></i><b>6.2</b> Signal of an ion chamber</a></li>
<li class="chapter" data-level="6.3" data-path="measurement.html"><a href="measurement.html#temperature-and-pressure-correction"><i class="fa fa-check"></i><b>6.3</b> Temperature and pressure correction</a></li>
<li class="chapter" data-level="6.4" data-path="measurement.html"><a href="measurement.html#guard-electrode"><i class="fa fa-check"></i><b>6.4</b> Guard electrode</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="quality.html"><a href="quality.html"><i class="fa fa-check"></i><b>7</b> Quality of X-rays</a></li>
<li class="chapter" data-level="8" data-path="dose.html"><a href="dose.html"><i class="fa fa-check"></i><b>8</b> Absorbed Dose</a><ul>
<li class="chapter" data-level="8.1" data-path="dose.html"><a href="dose.html#optical-density"><i class="fa fa-check"></i><b>8.1</b> Optical density</a></li>
<li class="chapter" data-level="8.2" data-path="dose.html"><a href="dose.html#q9-od"><i class="fa fa-check"></i><b>8.2</b> Q9 OD</a></li>
</ul></li>
<li class="chapter" data-level="9" data-path="distribution.html"><a href="distribution.html"><i class="fa fa-check"></i><b>9</b> Dose Distributions</a><ul>
<li class="chapter" data-level="9.1" data-path="distribution.html"><a href="distribution.html#tar"><i class="fa fa-check"></i><b>9.1</b> TAR</a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="dosecalc.html"><a href="dosecalc.html"><i class="fa fa-check"></i><b>10</b> Dose calcuation</a></li>
<li class="chapter" data-level="11" data-path="planning1.html"><a href="planning1.html"><i class="fa fa-check"></i><b>11</b> Treatment Planning I: Isodose Distribution and Plan Evaluation</a><ul>
<li class="chapter" data-level="11.1" data-path="planning1.html"><a href="planning1.html#penumbra-1"><i class="fa fa-check"></i><b>11.1</b> Penumbra</a></li>
<li class="chapter" data-level="11.2" data-path="planning1.html"><a href="planning1.html#wedges"><i class="fa fa-check"></i><b>11.2</b> Wedges</a></li>
</ul></li>
<li class="chapter" data-level="12" data-path="planning2.html"><a href="planning2.html"><i class="fa fa-check"></i><b>12</b> Treatment Planning II: Patient Data, Corrections, and Setup</a><ul>
<li class="chapter" data-level="12.1" data-path="planning2.html"><a href="planning2.html#inhomogeneity"><i class="fa fa-check"></i><b>12.1</b> Inhomogeneity</a></li>
<li class="chapter" data-level="12.2" data-path="planning2.html"><a href="planning2.html#range"><i class="fa fa-check"></i><b>12.2</b> Range</a></li>
<li class="chapter" data-level="12.3" data-path="planning2.html"><a href="planning2.html#mri"><i class="fa fa-check"></i><b>12.3</b> MRI</a></li>
<li class="chapter" data-level="12.4" data-path="planning2.html"><a href="planning2.html#pet"><i class="fa fa-check"></i><b>12.4</b> PET</a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="planning3.html"><a href="planning3.html"><i class="fa fa-check"></i><b>13</b> Treatment Planning III: Field shaping, skin dose, and field separation</a><ul>
<li class="chapter" data-level="13.1" data-path="planning3.html"><a href="planning3.html#hvl"><i class="fa fa-check"></i><b>13.1</b> HVL</a></li>
<li class="chapter" data-level="13.2" data-path="planning3.html"><a href="planning3.html#q2-3-4-and-7-range"><i class="fa fa-check"></i><b>13.2</b> Q2, 3, 4, and 7 Range</a></li>
</ul></li>
<li class="chapter" data-level="14" data-path="electron.html"><a href="electron.html"><i class="fa fa-check"></i><b>14</b> Electron</a><ul>
<li class="chapter" data-level="14.1" data-path="electron.html"><a href="electron.html#history-2"><i class="fa fa-check"></i><b>14.1</b> History</a></li>
<li class="chapter" data-level="14.2" data-path="electron.html"><a href="electron.html#treatment-sites"><i class="fa fa-check"></i><b>14.2</b> Treatment Sites</a></li>
<li class="chapter" data-level="14.3" data-path="electron.html"><a href="electron.html#e-interactions"><i class="fa fa-check"></i><b>14.3</b> Interactions</a></li>
<li class="chapter" data-level="14.4" data-path="electron.html"><a href="electron.html#e-delivery"><i class="fa fa-check"></i><b>14.4</b> Delivery</a></li>
<li class="chapter" data-level="14.5" data-path="electron.html"><a href="electron.html#beam-quality"><i class="fa fa-check"></i><b>14.5</b> Beam quality</a></li>
<li class="chapter" data-level="14.6" data-path="electron.html"><a href="electron.html#internal-shielding"><i class="fa fa-check"></i><b>14.6</b> Internal shielding</a></li>
<li class="chapter" data-level="14.7" data-path="electron.html"><a href="electron.html#total-skin-electron-irradiation-tsei"><i class="fa fa-check"></i><b>14.7</b> Total skin electron irradiation (TSEI)</a></li>
<li class="chapter" data-level="14.8" data-path="electron.html"><a href="electron.html#e-solu"><i class="fa fa-check"></i><b>14.8</b> Solutions</a></li>
</ul></li>
<li class="chapter" data-level="15" data-path="brachy.html"><a href="brachy.html"><i class="fa fa-check"></i><b>15</b> Brachytherapy</a><ul>
<li class="chapter" data-level="15.1" data-path="brachy.html"><a href="brachy.html#important-things-to-know"><i class="fa fa-check"></i><b>15.1</b> Important things to know</a></li>
<li class="chapter" data-level="15.2" data-path="brachy.html"><a href="brachy.html#isotopes"><i class="fa fa-check"></i><b>15.2</b> Isotopes</a><ul>
<li class="chapter" data-level="15.2.1" data-path="brachy.html"><a href="brachy.html#radium-sources"><i class="fa fa-check"></i><b>15.2.1</b> Radium sources</a></li>
<li class="chapter" data-level="15.2.2" data-path="brachy.html"><a href="brachy.html#radium-substitutes"><i class="fa fa-check"></i><b>15.2.2</b> Radium substitutes</a></li>
</ul></li>
<li class="chapter" data-level="15.3" data-path="brachy.html"><a href="brachy.html#source-strength"><i class="fa fa-check"></i><b>15.3</b> Source strength</a><ul>
<li class="chapter" data-level="15.3.1" data-path="brachy.html"><a href="brachy.html#sk"><i class="fa fa-check"></i><b>15.3.1</b> Unit: Air-kerma strength <span class="math inline">\(S_k\)</span></a></li>
</ul></li>
<li class="chapter" data-level="15.4" data-path="brachy.html"><a href="brachy.html#radiation-dose-from-brachytherpay-sources"><i class="fa fa-check"></i><b>15.4</b> Radiation dose from brachytherpay sources</a><ul>
<li class="chapter" data-level="15.4.1" data-path="brachy.html"><a href="brachy.html#from-exposure-rate"><i class="fa fa-check"></i><b>15.4.1</b> From exposure rate</a></li>
<li class="chapter" data-level="15.4.2" data-path="brachy.html"><a href="brachy.html#tg43"><i class="fa fa-check"></i><b>15.4.2</b> TG-43</a></li>
</ul></li>
<li class="chapter" data-level="15.5" data-path="brachy.html"><a href="brachy.html#ldr-solutions"><i class="fa fa-check"></i><b>15.5</b> Solutions</a></li>
<li class="chapter" data-level="15.6" data-path="brachy.html"><a href="brachy.html#traceability"><i class="fa fa-check"></i><b>15.6</b> Traceability</a></li>
<li class="chapter" data-level="15.7" data-path="brachy.html"><a href="brachy.html#tg-167-see-table-reftabtg167"><i class="fa fa-check"></i><b>15.7</b> TG-167 (see Table @ref(tab:tg167))</a></li>
</ul></li>
<li class="chapter" data-level="16" data-path="protection.html"><a href="protection.html"><i class="fa fa-check"></i><b>16</b> Radiation Protection</a><ul>
<li class="chapter" data-level="16.1" data-path="protection.html"><a href="protection.html#sources-of-radiation-exposure"><i class="fa fa-check"></i><b>16.1</b> Sources of radiation exposure</a></li>
<li class="chapter" data-level="16.2" data-path="protection.html"><a href="protection.html#stochastic-and-deterministic-event"><i class="fa fa-check"></i><b>16.2</b> Stochastic and deterministic event</a></li>
<li class="chapter" data-level="16.3" data-path="protection.html"><a href="protection.html#tds-rule"><i class="fa fa-check"></i><b>16.3</b> TDS rule</a></li>
</ul></li>
<li class="chapter" data-level="17" data-path="qa.html"><a href="qa.html"><i class="fa fa-check"></i><b>17</b> QA</a><ul>
<li class="chapter" data-level="17.1" data-path="qa.html"><a href="qa.html#patient-specific-qa"><i class="fa fa-check"></i><b>17.1</b> Patient-specific QA</a></li>
<li class="chapter" data-level="17.2" data-path="qa.html"><a href="qa.html#quality-and-safety"><i class="fa fa-check"></i><b>17.2</b> Quality and safety</a></li>
</ul></li>
<li class="chapter" data-level="18" data-path="tbi.html"><a href="tbi.html"><i class="fa fa-check"></i><b>18</b> TBI</a></li>
<li class="chapter" data-level="19" data-path="crt.html"><a href="crt.html"><i class="fa fa-check"></i><b>19</b> Three-dimensional conformal radiotherapy</a><ul>
<li class="chapter" data-level="19.1" data-path="crt.html"><a href="crt.html#icru-reference-point"><i class="fa fa-check"></i><b>19.1</b> ICRU reference point</a></li>
<li class="chapter" data-level="19.2" data-path="crt.html"><a href="crt.html#image-registration"><i class="fa fa-check"></i><b>19.2</b> Image registration</a></li>
<li class="chapter" data-level="19.3" data-path="crt.html"><a href="crt.html#image-segmentation"><i class="fa fa-check"></i><b>19.3</b> Image segmentation</a></li>
<li class="chapter" data-level="19.4" data-path="crt.html"><a href="crt.html#cumulative-dvh"><i class="fa fa-check"></i><b>19.4</b> Cumulative DVH</a></li>
<li class="chapter" data-level="19.5" data-path="crt.html"><a href="crt.html#differential-dvh"><i class="fa fa-check"></i><b>19.5</b> Differential DVH</a></li>
</ul></li>
<li class="chapter" data-level="20" data-path="imrt.html"><a href="imrt.html"><i class="fa fa-check"></i><b>20</b> IMRT</a><ul>
<li class="chapter" data-level="20.1" data-path="imrt.html"><a href="imrt.html#imrt"><i class="fa fa-check"></i><b>20.1</b> IMRT</a></li>
<li class="chapter" data-level="20.2" data-path="imrt.html"><a href="imrt.html#psqa"><i class="fa fa-check"></i><b>20.2</b> IMRT QA</a></li>
<li class="chapter" data-level="20.3" data-path="imrt.html"><a href="imrt.html#transmission-or-leakage"><i class="fa fa-check"></i><b>20.3</b> Transmission or leakage</a></li>
<li class="chapter" data-level="20.4" data-path="imrt.html"><a href="imrt.html#q4-mu-imrt-vs.3dcrt"><i class="fa fa-check"></i><b>20.4</b> Q4 MU: IMRT vs. 3DCRT</a></li>
<li class="chapter" data-level="20.5" data-path="imrt.html"><a href="imrt.html#q5"><i class="fa fa-check"></i><b>20.5</b> Q5</a></li>
<li class="chapter" data-level="20.6" data-path="imrt.html"><a href="imrt.html#shielding-for-imrt"><i class="fa fa-check"></i><b>20.6</b> Shielding for IMRT</a></li>
<li class="chapter" data-level="20.7" data-path="imrt.html"><a href="imrt.html#section"><i class="fa fa-check"></i><b>20.7</b> </a></li>
<li class="chapter" data-level="20.8" data-path="imrt.html"><a href="imrt.html#q8"><i class="fa fa-check"></i><b>20.8</b> Q8</a></li>
<li class="chapter" data-level="20.9" data-path="imrt.html"><a href="imrt.html#q9"><i class="fa fa-check"></i><b>20.9</b> Q9</a></li>
<li class="chapter" data-level="20.10" data-path="imrt.html"><a href="imrt.html#q10"><i class="fa fa-check"></i><b>20.10</b> Q10</a></li>
<li class="chapter" data-level="20.11" data-path="imrt.html"><a href="imrt.html#mlc-tests"><i class="fa fa-check"></i><b>20.11</b> MLC test(s)</a></li>
<li class="chapter" data-level="20.12" data-path="imrt.html"><a href="imrt.html#q12"><i class="fa fa-check"></i><b>20.12</b> Q12</a></li>
</ul></li>
<li class="chapter" data-level="21" data-path="sbrt.html"><a href="sbrt.html"><i class="fa fa-check"></i><b>21</b> SBRT</a><ul>
<li class="chapter" data-level="21.1" data-path="sbrt.html"><a href="sbrt.html#milestones"><i class="fa fa-check"></i><b>21.1</b> Milestones</a></li>
<li class="chapter" data-level="21.2" data-path="sbrt.html"><a href="sbrt.html#the-definition-of-srs-and-sbrt"><i class="fa fa-check"></i><b>21.2</b> The definition of SRS and SBRT</a></li>
<li class="chapter" data-level="21.3" data-path="sbrt.html"><a href="sbrt.html#features-of-gamma-knife-perfexiontm-and-icontm"><i class="fa fa-check"></i><b>21.3</b> Features of GAMMA Knife Perfexion<sup>TM</sup> and Icon<sup>TM</sup></a><ul>
<li class="chapter" data-level="21.3.1" data-path="sbrt.html"><a href="sbrt.html#stereotactic-reference"><i class="fa fa-check"></i><b>21.3.1</b> Stereotactic reference</a></li>
<li class="chapter" data-level="21.3.2" data-path="sbrt.html"><a href="sbrt.html#steps-to-create-new-plan"><i class="fa fa-check"></i><b>21.3.2</b> Steps to create new plan</a></li>
</ul></li>
<li class="chapter" data-level="21.4" data-path="sbrt.html"><a href="sbrt.html#gk-white-papers"><i class="fa fa-check"></i><b>21.4</b> GK White Papers</a><ul>
<li class="chapter" data-level="21.4.1" data-path="sbrt.html"><a href="sbrt.html#accuracy-of-co-registration-of-planning-images-with-cone-beam-ct-images"><i class="fa fa-check"></i><b>21.4.1</b> Accuracy of co-registration of planning images with Cone Beam CT images</a></li>
<li class="chapter" data-level="21.4.2" data-path="sbrt.html"><a href="sbrt.html#automatic-positional-delivery-correction-using-a-stereotactic-cbct-in-gk-icontm"><i class="fa fa-check"></i><b>21.4.2</b> Automatic positional delivery correction using a stereotactic CBCT in GK Icon<sup>TM</sup></a></li>
</ul></li>
<li class="chapter" data-level="21.5" data-path="sbrt.html"><a href="sbrt.html#gk-troubleshooting"><i class="fa fa-check"></i><b>21.5</b> GK Troubleshooting</a></li>
<li class="chapter" data-level="21.6" data-path="sbrt.html"><a href="sbrt.html#qa-of-gk"><i class="fa fa-check"></i><b>21.6</b> QA of GK</a><ul>
<li class="chapter" data-level="21.6.1" data-path="sbrt.html"><a href="sbrt.html#prescision-and-accuracy"><i class="fa fa-check"></i><b>21.6.1</b> Prescision and accuracy</a></li>
</ul></li>
<li class="chapter" data-level="21.7" data-path="sbrt.html"><a href="sbrt.html#commissioning-of-gk"><i class="fa fa-check"></i><b>21.7</b> Commissioning of GK</a></li>
<li class="chapter" data-level="21.8" data-path="sbrt.html"><a href="sbrt.html#preparation-of-gk-treatment-planning"><i class="fa fa-check"></i><b>21.8</b> Preparation of GK Treatment Planning</a><ul>
<li class="chapter" data-level="21.8.1" data-path="sbrt.html"><a href="sbrt.html#frame-application-model-c"><i class="fa fa-check"></i><b>21.8.1</b> Frame Application: model C</a></li>
<li class="chapter" data-level="21.8.2" data-path="sbrt.html"><a href="sbrt.html#frame-application-perfexion"><i class="fa fa-check"></i><b>21.8.2</b> Frame application: Perfexion</a></li>
</ul></li>
<li class="chapter" data-level="21.9" data-path="sbrt.html"><a href="sbrt.html#gk-plan-indices"><i class="fa fa-check"></i><b>21.9</b> GK Plan Indices</a><ul>
<li class="chapter" data-level="21.9.1" data-path="sbrt.html"><a href="sbrt.html#systematic-errors"><i class="fa fa-check"></i><b>21.9.1</b> Systematic Errors</a></li>
</ul></li>
<li class="chapter" data-level="21.10" data-path="sbrt.html"><a href="sbrt.html#linac-based-srs"><i class="fa fa-check"></i><b>21.10</b> Linac-based SRS</a><ul>
<li class="chapter" data-level="21.10.1" data-path="sbrt.html"><a href="sbrt.html#cone-based"><i class="fa fa-check"></i><b>21.10.1</b> Cone-based</a></li>
</ul></li>
<li class="chapter" data-level="21.11" data-path="sbrt.html"><a href="sbrt.html#diesease-sites-treatment-with-srs"><i class="fa fa-check"></i><b>21.11</b> Diesease sites treatment with SRS</a><ul>
<li class="chapter" data-level="21.11.1" data-path="sbrt.html"><a href="sbrt.html#acoustic-neuoromas"><i class="fa fa-check"></i><b>21.11.1</b> Acoustic neuoromas</a></li>
<li class="chapter" data-level="21.11.2" data-path="sbrt.html"><a href="sbrt.html#arteriovenous-malforamtions-avm"><i class="fa fa-check"></i><b>21.11.2</b> Arteriovenous malforamtions (AVM)</a></li>
<li class="chapter" data-level="21.11.3" data-path="sbrt.html"><a href="sbrt.html#brain-metastases"><i class="fa fa-check"></i><b>21.11.3</b> Brain metastases</a></li>
<li class="chapter" data-level="21.11.4" data-path="sbrt.html"><a href="sbrt.html#malignant-gliomas"><i class="fa fa-check"></i><b>21.11.4</b> Malignant gliomas</a></li>
<li class="chapter" data-level="21.11.5" data-path="sbrt.html"><a href="sbrt.html#menningiomas"><i class="fa fa-check"></i><b>21.11.5</b> Menningiomas</a></li>
<li class="chapter" data-level="21.11.6" data-path="sbrt.html"><a href="sbrt.html#pituitary-tumors"><i class="fa fa-check"></i><b>21.11.6</b> Pituitary tumors</a></li>
<li class="chapter" data-level="21.11.7" data-path="sbrt.html"><a href="sbrt.html#unilateral-vestibular-schwannomas"><i class="fa fa-check"></i><b>21.11.7</b> Unilateral Vestibular Schwannomas</a></li>
<li class="chapter" data-level="21.11.8" data-path="sbrt.html"><a href="sbrt.html#uveal-melanomas"><i class="fa fa-check"></i><b>21.11.8</b> Uveal melanomas</a></li>
<li class="chapter" data-level="21.11.9" data-path="sbrt.html"><a href="sbrt.html#trigeminal-neuralgia"><i class="fa fa-check"></i><b>21.11.9</b> Trigeminal neuralgia</a></li>
</ul></li>
<li class="chapter" data-level="21.12" data-path="sbrt.html"><a href="sbrt.html#dose-fall-off"><i class="fa fa-check"></i><b>21.12</b> Dose fall-off</a></li>
<li class="chapter" data-level="21.13" data-path="sbrt.html"><a href="sbrt.html#required-measurements-for-commissioning-a-srssbrt-program"><i class="fa fa-check"></i><b>21.13</b> Required measurements for commissioning a SRS/SBRT program</a></li>
</ul></li>
<li class="chapter" data-level="22" data-path="hdr.html"><a href="hdr.html"><i class="fa fa-check"></i><b>22</b> HDR</a><ul>
<li class="chapter" data-level="22.1" data-path="hdr.html"><a href="hdr.html#hdr-vs.ldr"><i class="fa fa-check"></i><b>22.1</b> HDR vs. LDR</a></li>
<li class="chapter" data-level="22.2" data-path="hdr.html"><a href="hdr.html#common-indications-in-practice"><i class="fa fa-check"></i><b>22.2</b> Common indications in practice</a></li>
<li class="chapter" data-level="22.3" data-path="hdr.html"><a href="hdr.html#hdr-qa"><i class="fa fa-check"></i><b>22.3</b> HDR-QA</a><ul>
<li class="chapter" data-level="22.3.1" data-path="hdr.html"><a href="hdr.html#daily-qa"><i class="fa fa-check"></i><b>22.3.1</b> Daily QA</a></li>
<li class="chapter" data-level="22.3.2" data-path="hdr.html"><a href="hdr.html#pretreatment-qa-tg-59"><i class="fa fa-check"></i><b>22.3.2</b> Pretreatment QA (TG-59)</a></li>
<li class="chapter" data-level="22.3.3" data-path="hdr.html"><a href="hdr.html#hdr-source-change"><i class="fa fa-check"></i><b>22.3.3</b> Source change</a></li>
</ul></li>
<li class="chapter" data-level="22.4" data-path="hdr.html"><a href="hdr.html#medical-events"><i class="fa fa-check"></i><b>22.4</b> Medical Events</a></li>
<li class="chapter" data-level="22.5" data-path="hdr.html"><a href="hdr.html#source"><i class="fa fa-check"></i><b>22.5</b> Source</a></li>
<li class="chapter" data-level="22.6" data-path="hdr.html"><a href="hdr.html#treatment-sites-1"><i class="fa fa-check"></i><b>22.6</b> Treatment sites</a><ul>
<li class="chapter" data-level="22.6.1" data-path="hdr.html"><a href="hdr.html#endometrial-cancer"><i class="fa fa-check"></i><b>22.6.1</b> Endometrial cancer</a></li>
<li class="chapter" data-level="22.6.2" data-path="hdr.html"><a href="hdr.html#cervical"><i class="fa fa-check"></i><b>22.6.2</b> Cervical cancer</a></li>
<li class="chapter" data-level="22.6.3" data-path="hdr.html"><a href="hdr.html#breast"><i class="fa fa-check"></i><b>22.6.3</b> Breast</a></li>
<li class="chapter" data-level="22.6.4" data-path="hdr.html"><a href="hdr.html#prostate"><i class="fa fa-check"></i><b>22.6.4</b> Prostate</a></li>
</ul></li>
<li class="chapter" data-level="22.7" data-path="hdr.html"><a href="hdr.html#references"><i class="fa fa-check"></i><b>22.7</b> References</a></li>
<li class="chapter" data-level="22.8" data-path="hdr.html"><a href="hdr.html#solutions-3"><i class="fa fa-check"></i><b>22.8</b> Solutions</a></li>
</ul></li>
<li class="chapter" data-level="23" data-path="implants.html"><a href="implants.html"><i class="fa fa-check"></i><b>23</b> Implants</a><ul>
<li class="chapter" data-level="23.1" data-path="implants.html"><a href="implants.html#isotopes-1"><i class="fa fa-check"></i><b>23.1</b> Isotopes</a></li>
<li class="chapter" data-level="23.2" data-path="implants.html"><a href="implants.html#patient-release"><i class="fa fa-check"></i><b>23.2</b> Patient Release</a></li>
<li class="chapter" data-level="23.3" data-path="implants.html"><a href="implants.html#prostate-implants"><i class="fa fa-check"></i><b>23.3</b> Prostate implants</a></li>
<li class="chapter" data-level="23.4" data-path="implants.html"><a href="implants.html#y90"><i class="fa fa-check"></i><b>23.4</b> TheraSphere</a></li>
</ul></li>
<li class="chapter" data-level="24" data-path="ivbt.html"><a href="ivbt.html"><i class="fa fa-check"></i><b>24</b> Intravascular BT</a></li>
<li class="chapter" data-level="25" data-path="igrt.html"><a href="igrt.html"><i class="fa fa-check"></i><b>25</b> IGRT</a></li>
<li class="chapter" data-level="26" data-path="cyber-knife.html"><a href="cyber-knife.html"><i class="fa fa-check"></i><b>26</b> Cyber Knife</a></li>
<li class="chapter" data-level="27" data-path="proton.html"><a href="proton.html"><i class="fa fa-check"></i><b>27</b> Proton RT</a></li>
<li class="chapter" data-level="28" data-path="varian.html"><a href="varian.html"><i class="fa fa-check"></i><b>28</b> Varian</a><ul>
<li class="chapter" data-level="28.1" data-path="varian.html"><a href="varian.html#clinac-couch"><i class="fa fa-check"></i><b>28.1</b> Clinac couch</a></li>
</ul></li>
<li class="chapter" data-level="29" data-path="it.html"><a href="it.html"><i class="fa fa-check"></i><b>29</b> Information Technology</a><ul>
<li class="chapter" data-level="29.1" data-path="it.html"><a href="it.html#it-basics"><i class="fa fa-check"></i><b>29.1</b> IT basics</a></li>
<li class="chapter" data-level="29.2" data-path="it.html"><a href="it.html#dicom"><i class="fa fa-check"></i><b>29.2</b> DICOM</a></li>
<li class="chapter" data-level="29.3" data-path="it.html"><a href="it.html#database-basics"><i class="fa fa-check"></i><b>29.3</b> Database basics</a></li>
<li class="chapter" data-level="29.4" data-path="it.html"><a href="it.html#programming"><i class="fa fa-check"></i><b>29.4</b> Programming</a></li>
</ul></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">MP</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="brachy" class="section level1">
<h1><span class="header-section-number">Chapter 15</span> Brachytherapy</h1>
<blockquote>
<p>Brachytherapy began at the turn of 20th century, contemporary with external beam radiotherapy. Physicsits and physicians together developed the field. There has not been a period since the beginning that has not witnessed innovations and progress in brachytherapy</p>
<p>— B.R. Thomadsen in “Anniversary paper: past and current issues in brachytherapy physics”</p>
</blockquote>
<div id="important-things-to-know" class="section level2">
<h2><span class="header-section-number">15.1</span> Important things to know</h2>
<p>Dose rates defined in ICRU 38 (1985) and 10 CFR 35</p>
<ul>
<li>Ultralow dose rate: <strong>0.01-0.3 Gy/hr</strong> (prostate implants)</li>
<li>Low dose rate: 0.4-2.0 Gy/hr</li>
<li>Medium dose rate: 2-12 Gy/hr</li>
<li>High dose rate: <strong>&gt;12 Gy/h</strong>; modern HDR can deliver about <strong>430 Gy/hr</strong></li>
<li>Pulsed dose rate</li>
</ul>
<p>Brachytherapy category depending on placement of sources</p>
<ul>
<li>Plaques or mold - eye plaques</li>
<li>Interstitial - prostate implants</li>
<li>Intracaitary - HDR cylinder</li>
<li>Intraluminal - Bile duct, esophagus, IVBT</li>
</ul>
</div>
<div id="isotopes" class="section level2">
<h2><span class="header-section-number">15.2</span> Isotopes</h2>
<div id="radium-sources" class="section level3">
<h3><span class="header-section-number">15.2.1</span> Radium sources</h3>
<p>Radiumsources used for implant therapy contain Ra-226 in <span class="math inline">\(\color{Green}{\text{secular equilibrium}}\)</span> (takes about 1 month, see Section <a href="nut.html#decays">2.1</a>) with its decay products (stable Pb-206).<a href="#fn12" class="footnoteRef" id="fnref12"><sup>12</sup></a></p>
<p>The exposure rate from a 1 mCi point source of <sup>226</sup>Ra that is in secular equilibrium with its decay products and enclosed within a 0.5 mmPt-Ir wall is 8.25 R/hr at a distance of 1 cm. The value of <strong>8.25 R<span class="math inline">\(\cdot\)</span>cm<sup>2</sup>/hr<span class="math inline">\(\cdot\)</span>mCi</strong> is referred to as the <span class="math inline">\(\color{Green}{\text{exposure rate constant}}\)</span>.</p>
</div>
<div id="radium-substitutes" class="section level3">
<h3><span class="header-section-number">15.2.2</span> Radium substitutes</h3>
<table>
<caption><span id="tab:isotopes">Table 15.1: </span> Frequently used radioactive isotopes<a href="#fn13" class="footnoteRef" id="fnref13"><sup>13</sup></a></caption>
<thead>
<tr class="header">
<th>Isotope</th>
<th><span class="math inline">\(T_{1/2}\)</span> (days)</th>
<th>Median E (KeV)</th>
<th>HVL (mm lead)</th>
<th>usage</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Cs-137</td>
<td>30 years</td>
<td>660</td>
<td>5.5</td>
<td>-</td>
</tr>
<tr class="even">
<td>Ir-192</td>
<td>74</td>
<td>400</td>
<td>2.5</td>
<td>interstitial implantation (in ribbon)</td>
</tr>
<tr class="odd">
<td>I-125</td>
<td>60</td>
<td>28</td>
<td>0.025</td>
<td>prostate implants (<a href="implants.html#implants">23</a>), eye plaques</td>
</tr>
<tr class="even">
<td>Pd-103</td>
<td>17</td>
<td>22</td>
<td>0.01</td>
<td>prostate implants (<a href="implants.html#implants">23</a>)</td>
</tr>
<tr class="odd">
<td>Cs-131</td>
<td>10</td>
<td>29</td>
<td>-</td>
<td>intracavitary BT of uterine cervix</td>
</tr>
<tr class="even">
<td>Au-198</td>
<td>2.5</td>
<td>400</td>
<td>2.5</td>
<td>eye plaque</td>
</tr>
<tr class="odd">
<td>Y90 (<span class="math inline">\(\beta\)</span> emitter)</td>
<td>2.67</td>
<td>937</td>
<td>-</td>
<td>liver radioembolism</td>
</tr>
</tbody>
</table>
<p>Radiation safety of brachytherapy sources</p>
<ul>
<li>Storage - shielding container; forceps, personal dosimetry</li>
<li>Test for tumor distribution of activity - <code>autoradiography</code> using films (exposure distribution + source physicial position and shape)</li>
<li>Evaluation the safety - <code>leak test</code> (the source is swapped with a moistened cotton swab, which is then placed into a <code>scintellation</code> counter)</li>
</ul>
</div>
</div>
<div id="source-strength" class="section level2">
<h2><span class="header-section-number">15.3</span> Source strength</h2>
<ul>
<li>Radium sources has been specified in terms of <code>mass</code> of radium</li>
<li>Cesium sources was specified in terms of <code>milligram equivalents of radium</code> (mg<span class="math inline">\(\cdot\)</span>Ra<span class="math inline">\(\cdot\)</span>eq)</li>
<li>Sources can also be specified in terms of activity; the <code>apparent activity</code>, of a source is determined from a measurement of the exposure rate at a distance; it describes the activity of that nuclide that would produce the same exposure rate when unencapsulated.</li>
<li>AAPM recommend <code>air-kerma strength</code></li>
</ul>
<div id="sk" class="section level3">
<h3><span class="header-section-number">15.3.1</span> Unit: Air-kerma strength <span class="math inline">\(S_k\)</span></h3>
<p><code>Air-kerma strength</code> (S<sub>k</sub>) of brachytherapy sources is is defined as the <code>air-kerma rate</code> (<span class="math inline">\(\dot{K}_{\delta}\)</span>) at a reference distance (e.g. 1 m) from the source center along the perpendicular bisector. The air-kerma strength is related to the quantity exposure rate by<a href="#fn14" class="footnoteRef" id="fnref14"><sup>14</sup></a></p>
<span class="math display" id="eq:sk">\[\begin{equation}
  S_k =\dot K_\delta \cdot d^2 = \dot X(d) \cdot  \left( \frac{\bar W}{e}\right) \cdot d^2,
  \tag{15.1}
\end{equation}\]</span>
<p>The SI unit of air-kerma strength Gy m<sup>2</sup> s<sup>-1</sup> or <strong><span class="math inline">\(\mu\)</span>Gy m<sup>2</sup> h<sup>-1</sup></strong>. The exposure rate <span class="math inline">\(\dot X(d)\)</span> is measured using an ion chamber, a “reentrant”-type well chamber, or a dose calibrator supplied with a suitable standard source. The term <span class="math inline">\(({\bar W}/e )\)</span> is the averagy energy to create an ion pair (<strong>0.876 cGy/R</strong>).</p>
<p>The international community uses the term of <code>reference air-kerma rate</code> (RAKR), which is defined as the air kerma rate at 1 m from the source in <span class="math inline">\(\mu Gy h^{-1}\)</span></p>
</div>
</div>
<div id="radiation-dose-from-brachytherpay-sources" class="section level2">
<h2><span class="header-section-number">15.4</span> Radiation dose from brachytherpay sources</h2>
<div id="from-exposure-rate" class="section level3">
<h3><span class="header-section-number">15.4.1</span> From exposure rate</h3>
<p>Early prescriptions for brachytherapy treatments were expressed in terms of radiation exposure.</p>
The exposure rate (in R/hr) at some distance, r (cm), from a point source of radioactive material is:
<span class="math display" id="eq:exposure">\[\begin{equation}
   \dot X = \frac{\Gamma_{\delta}A}{r^2}
   \tag{15.2}
\end{equation}\]</span>
<p>where A is the activity of the source, and <span class="math inline">\(\Gamma_{\delta}\)</span> is the <code>exposure rate constant</code> for the nuclide. For example, <span class="math inline">\(\Gamma_{\delta}\)</span> is 3.28, 4.62, 1.45, and 1.48 R<span class="math inline">\(\cdot\)</span>cm<sup>2</sup>/hr<span class="math inline">\(\cdot\)</span>mCi for <sup>137</sup>Cs, <sup>192</sup>Ir, <sup>125</sup>I, and <sup>103</sup>Pd, respectively.</p>
The resulting <code>Sievert integral</code> is shown
<span class="math display">\[\begin{equation}
   \dot D(r, \theta) = \frac{\Gamma_{\delta}Af}{lr}\int^{\theta_2}_{\theta_1}e^{-\mu t/cos{\theta}}d\theta
\end{equation}\]</span>
<p>where f is the <span class="math inline">\(f\)</span> factor (exposure to dose conversion), <span class="math inline">\(l\)</span> is the length of source.</p>
<p>Although the effects of photon scatter and attenuation in tissue are neglected, dose calculations can be reasonably accurate because contributions of scattered radiation to a point very nearly compensate for the tissue attenuation of radiation reaching the same point.</p>
</div>
<div id="tg43" class="section level3">
<h3><span class="header-section-number">15.4.2</span> TG-43</h3>
<p>Most brachytherapy dose calculations are now based on TG-43 and its updates<a href="#fn15" class="footnoteRef" id="fnref15"><sup>15</sup></a> and are done using computer programs. It should be noted that most current dose calculation still assumes that all material is <strong>water equivalent</strong>.</p>
<p>The four principal factors influencing the relative dose distribution include: 1) <strong>Distance</strong> - a factor of 100 between the distances of 0.5 and 5 cm while the remaining factors over the same distance range rarely exceeds a factor of 2 or 3; 2) <strong>Attenuation and scattering in source structure</strong> - the dose near the longitudinal axis is usually smaller than on the transverse axis; 3) <strong>Attenuation by surrounding medium</strong> - compton scattering and photoelectric absorption; 4) <strong>Accumulation of scattering in surrounding medium</strong>.</p>
Although the manual calculation is not needed, it is helpful to understand how the dose distributions are calculated in TG-43. In TG-43, the dose rate distribution around a sealed brachytherapy source can be determined in two-dimensions (2D) using the following equation:
<span class="math display" id="eq:tg43">\[\begin{equation}
   \dot D(r, \theta) = \Lambda S_k \frac{G_L(r, \theta)}{G_L(r=1cm,\theta=90^o)} g_L(r, \theta) F(r,\theta),
   \tag{15.3}
\end{equation}\]</span>
or a simplified 1D version
<span class="math display" id="eq:tg43-1D">\[\begin{equation}
   \dot D(r) = \Lambda S_k \frac{1}{r^2} G_p(r)\phi_{an}(r),
   \tag{15.4}
\end{equation}\]</span>
<p>where r denotes the distance (cm) from the center of the active source to the point of interest and <span class="math inline">\(\theta\)</span> is the point of interest relative to the source longitudinal axis.</p>
<div class="figure">
<img src="figures\tg43.jpg" alt="TG 43" />
<p class="caption">TG 43</p>
</div>
<p><strong>Dose rate constant</strong></p>
The <code>dose-rate constant</code> is defined as:
<span class="math display" id="eq:dose-rate-constant">\[\begin{equation}
   \Lambda = \frac{\dot D(r_0, \theta_0)}{S_k}.
   \tag{15.5}
\end{equation}\]</span>
<p>It can be thought as the dose rate in water at a reference point (<span class="math inline">\(r_0\)</span> = 1 cm for photon sources and 2 mm for beta emitters) along the transverse axis (<span class="math inline">\(\theta = 90^{\circ }\)</span>) for source strength of 1 U.</p>
<p><strong>Radial dose function and geometry function</strong></p>
The <code>radial dose function</code> g(r) represents the attenuation of radiation in tissue, defined as<br />

<span class="math display">\[\begin{equation}
g(r) = \frac{\dot D(r,90^{\circ})\cdot G(r_0,90^{\circ})}{\dot D(r_0,90^{\circ})\cdot G(r, 90^{\circ})}.
\end{equation}\]</span>
<p>where <span class="math inline">\(G(r,\theta)\)</span> is the <code>geometry function</code> which accounts for the effect of the distribution of radioactive material inside the source on the dose distribution at a given point. It is equal to <span class="math inline">\(1/r^2\)</span> for point source approximation, <span class="math inline">\(\frac{tan^{-1}[(x+L/2)/y]-tan^{-1}[(x-L/2)/y]}{Ly}\)</span> or <span class="math inline">\(\frac{1}{x^2-(L/2)^2}\)</span> for linear source approximation with <span class="math inline">\(\theta \neq 0^{\circ}\)</span> or <span class="math inline">\(\theta = 0^{\circ}\)</span> and <span class="math inline">\(x&gt;L/2\)</span>.</p>
<p><strong>Anisotrpic function</strong></p>
<span class="math inline">\(F(r,\theta)\)</span> is the <code>anisotropy function</code>, defined as
<span class="math display">\[\begin{equation}
F(r,\theta) = \frac{\dot D(r,\theta)\cdot G(r,90^{\circ})}{\dot D(r,90^{\circ})\cdot G(r, \theta)}.
\end{equation}\]</span>
<p>It accounts for anisotropy of dose distribution around the source, including effects of absorption and scatter in medium, i.e., self-filtration in source, oblique filtration in walls, scattering and absorption in tissue. In TG-43U, typically calculated from Monte Carlo.</p>
<p>The example information about Elekta Flexisource can be seen in the figure below <img src="figures\Ir-192.jpg" /><!-- --></p>
In brachytherapy there is a rapid falloff in dose as distance from the source increases due to inverse square law. The dose within the tumor may much different from the prescription dose, thus the concept of equivalent uniform dose (EUD) was introduced by Dale et al. (1997). Mathematically, the generalized EUD is defined as
<span class="math display">\[\begin{equation*}
EUD= \left( \sum \nu_iD^a_i \right ) ^{1/a}
\end{equation*}\]</span>
<p>Here <span class="math inline">\(\nu_i\)</span> is the fractional organ volume receiving a dose <span class="math inline">\(D_i\)</span> and a is a tissue-specific parameter that describes the volume effect.</p>
<ul>
<li><span class="math inline">\(a \rightarrow -\infty\)</span>, EUD = minimum dose;</li>
<li><span class="math inline">\(a \rightarrow -\infty\)</span>, EUD = maximum dose (serial organs);</li>
<li>a = 1, EUD = mean dose;</li>
<li>a = 2, EUD = RMS dose.</li>
</ul>
<p>The EUD model is parameterized by the single biological parameter a, which should be chosen so that the EUD reflects the intended biological properties for the given tumor or organ. Parameter a and the Lyman model parameter n are related by a = 1/n Tumor: a is a negative number (e.g., a = -15) Normal tissues: a is a positive number</p>
<p>The volume-effect: very small normal tissue volumes (e.g. 1-2 cm3) can tolerate very high doses that larger volumes would not tolerate. There are a few exceptions to this such as spinal cord, though the dose as high as 167.3 Gy to the cord has been reported in very low dose rate brachytherapy of paraspinal tumor. Rogers et al. (2002) reported that the mean cord dose was 72.5 Gy (ranging: 53.1-167.3 Gy), combining the EBRT and I-125 brachytherapy.</p>
</div>
</div>
<div id="ldr-solutions" class="section level2">
<h2><span class="header-section-number">15.5</span> Solutions</h2>
<p><code>Q1 d)</code></p>
<p>As <span class="math inline">\(D = \dot D\times\Delta t\)</span>, <span class="math inline">\(\frac{\Delta t_{new}}{\Delta t_{old}}=\frac{\dot D_{old}}{\dot D_{new}} = \frac{A_{old}}{A_{new}} = \frac{A_0e^{-10/30}}{A_0} = 0.79\)</span></p>
<p><code>Q2 Shielding b)</code><br />
Although the average energy of <sup>60</sup>Co is higher than that of <sup>226</sup>Ra, there are gamma rays of 1.76 and 2.2 MeV emitted from <sup>226</sup>Ra sources. In shielding design, we need to consider their existence (although their contribution is small) and thus HVL for <sup>226</sup>Ra is greater than HVL for <sup>60</sup>Co.<a href="#fn16" class="footnoteRef" id="fnref16"><sup>16</sup></a><br />
<code>Q3 a) b) c)</code> A <sup>137</sup>Cs source is normally used for consistence check (like linac monthly QA) but not calibration.<br />
<code>Q4 a)</code> Like external beam radiotherapy, the inverse square law is always the biggest factor for dose calculation.<br />
<code>Q5 a)</code> Should c) and d) be correct?<br />
<code>Q6 Initial dose rate c)</code></p>
<p>The prescription dose or total dose for an prostate implant is</p>
<span class="math display">\[\begin{equation*}
D = \int^{\infty}_0 \dot D_0 \cdot e^{-\frac{0.693}{T_{1/2}}t}dt
\end{equation*}\]</span>
<p>Using an important definite integral, <span class="math inline">\(\int^{\infty}_0 e^{-ax} dx = \frac{1}{a}\)</span>, we can find that</p>
<span class="math display">\[\begin{equation*}
D = \dot D_0 \cdot \frac{T_{1/2}}{0.693} \rightarrow \dot D_0 = \frac{D}{59.4/0.693}=\frac{14400 \text{ cGy} \times 0.693}{59.4 \text{ days} \times 24 \text{ hours/day}} = \boxed{7.0\text{ cGy/hr}}
\end{equation*}\]</span>
<p><code>Q7 b)</code></p>
<p><code>Q8 The Paterson-Parker system c)</code><br />
<code>Q9 The Quimby system a)</code><br />
<code>Q10 The Paris system c) d)</code></p>
<p>The air kerma strength and <code>apparent activity</code> conversion is 1 U = 0.348, 0.243, 0.486, 0.787, and 0.773 mCi for <sup>137</sup>Cs, <sup>192</sup>Ir, <sup>198</sup>Au, <sup>125</sup>I, and <sup>103</sup>Pd, respectively.</p>
</div>
<div id="traceability" class="section level2">
<h2><span class="header-section-number">15.6</span> Traceability</h2>
<p>Calibrations of brachytherapy sources should be directly traced to NIST or to an Accredited Dosimetry Calibration Laboratory (ADCL) which is traced to NIST. Normally, we don’t send sources to NIST or ADCL, but instead a well chamber with specific inserts designed for different isotopes. To calibrate <a href="http://www.bardmedical.com/products/prostate-health/brachytherapy/source-and-delivery-systems/iodine-125/">Bard PS-1251L</a> I-125 sources, for instance, the well chamber with an I-125 insert will be used, which was checked using Bard PS-1251L I-125 sources at NIST or ADLC.</p>
<p>TG-40</p>
<ul>
<li>all long half-life sources should be calibrated;</li>
<li>at least 10% or 2 ribbons (whichever is larger) should be calibrated for a large number of loose seeds with <strong>short</strong> half-life.</li>
</ul>
<p>If the institution’s verification of source strength disagrees with the manufacturer’s data by more than 3%, the source of the disagreement should be investigated. We further recommend that an unresolved disparity exceeding 5% should be reported to the manufacturer.</p>
<p>Radioactive materials must be under control by the facility at all times. This means under direct control or by securing in a locked area.</p>
</div>
<div id="tg-167-see-table-reftabtg167" class="section level2">
<h2><span class="header-section-number">15.7</span> TG-167 (see Table <a href="brachy.html#tab:tg167">15.2</a>)</h2>
<table>
<caption>
<span id="tab:tg167">Table 15.2: </span>Brachytherapy sources and application considerations at our practice per TG-167
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
Ir-192
</th>
<th style="text-align:left;">
I-125 and Pd-103
</th>
<th style="text-align:left;">
IVBT
</th>
<th style="text-align:left;">
Y90
</th>
<th style="text-align:left;">
COMS
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Regulation
</td>
<td style="text-align:left;">
well established
</td>
<td style="text-align:left;">
well established
</td>
<td style="text-align:left;">
<span style="color:red">PMA, multi-displinary</span>
</td>
<td style="text-align:left;">
<span style="color:red">off-label, multi-displinary</span>
</td>
<td style="text-align:left;">
well established
</td>
</tr>
<tr>
<td style="text-align:left;">
Calibration
</td>
<td style="text-align:left;">
well established with ADCLs
</td>
<td style="text-align:left;">
NIST WAFAC + ADCLs
</td>
<td style="text-align:left;">
NIST traceability
</td>
<td style="text-align:left;">
<span style="color:red">difficult beta calibration</span>
</td>
<td style="text-align:left;">
need NIST traceability, <span style="color:red">many possibilities</span>
</td>
</tr>
<tr>
<td style="text-align:left;">
Dosimetry
</td>
<td style="text-align:left;">
well established, <span style="color:red">scatter importance</span>
</td>
<td style="text-align:left;">
well established, <span style="color:red">sensitive to tissue composition</span>
</td>
<td style="text-align:left;">
<span style="color:red">beta dosimetry, cylindrical formalism, no IGRT</span>
</td>
<td style="text-align:left;">
<span style="color:red">infeasible pre-treatment planning, need 3D dosimtry research</span>
</td>
<td style="text-align:left;">
<span style="color:red">need IGRT, not TG-43 compatible</span>
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiobiology
</td>
<td style="text-align:left;">
established in the 1990s
</td>
<td style="text-align:left;">
<span style="color:red">not typically addressed</span>
</td>
<td style="text-align:left;">
<span style="color:red">assumptions from HDR</span>
</td>
<td style="text-align:left;">
<span style="color:red">need patient-specific biokinetic models</span>
</td>
<td style="text-align:left;">
similar to HDR Ir-192
</td>
</tr>
</tbody>
</table>

</div>
</div>
<div class="footnotes">
<hr />
<ol start="12">
<li id="fn12"><p>The radium was supplied in the form of a salt, which was mixed with an inert filler such as magnesium oxide or barium sulfate. The small crystals of radium salt and filler were contained within cylindrical cells about 1 cm long. The cells were made of gold foil 0.1 to 0.2 mm thick and were sealed to prevent the escape of radon gas. Each source of radium contained 1 to 3 cells surrounded by a wall of platinum, reinforced with iridium (10%). The thickness (usually 0.5 or 1 mm) of the platinum-iridium wall was sufficient to absorb <span class="math inline">\(\alpha\)</span> and <span class="math inline">\(\beta\)</span> radiation from the source. Gamma rays were attenuated only slightly by the wall.<a href="brachy.html#fnref12">↩</a></p></li>
<li id="fn13"><p>Form the NIST table (<a href="https://physics.nist.gov/PhysRefData/XrayMassCoef/ComTab/water.html" class="uri">https://physics.nist.gov/PhysRefData/XrayMassCoef/ComTab/water.html</a>), the total attenuation coefficients in water are about 0.38, 0.1, and 0.09 cm<sup>-1</sup> for the photon energies of 30 (I-125), 400 (Au-198 and Ir-192), and 600 KeV (Cs-137), respectively. A good reference can be found at <a href="https://aapm.org/meetings/amos2/pdf/42-11873-3201-79.pdf" class="uri">https://aapm.org/meetings/amos2/pdf/42-11873-3201-79.pdf</a><a href="brachy.html#fnref13">↩</a></p></li>
<li id="fn14"><p>The equation above is a revised definition of air-kerma strength (new cutoff energy 5 keV); experimentally, an aluminum filter is put in front of <a href="https://www.nist.gov/programs-projects/calibration-low-energy-photon-brachytherapy-sources">NIST wide angle free-air chamber (WAFAC)</a> to get rid of photons with lower energies.<a href="brachy.html#fnref14">↩</a></p></li>
<li id="fn15"><p>Other TG 43 updates include: 1) eliminating apparent activity for specification of source strength, 2) eliminating the anisotropy constant in favor of the distance dependent 1-D anisotropy function, <span class="math inline">\(\phi_an(r)\)</span>, and 3) providing guidance on extrapolating tabulated TG-43 parameters to longer and shorter distance.<a href="brachy.html#fnref15">↩</a></p></li>
<li id="fn16"><p><a href="https://www.nrc.gov/docs/ML1122/ML11229A721.pdf" class="uri">https://www.nrc.gov/docs/ML1122/ML11229A721.pdf</a><a href="brachy.html#fnref16">↩</a></p></li>
</ol>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="electron.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="protection.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"linkedin": false,
"weibo": false,
"instapper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"download": ["MP.pdf", "MP.epub"],
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "";
    if (src === "" || src === "true") src = "https://cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:" && /^https?:/.test(src))
      src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
